William Blair & Company
HIMS icon

William Blair & Company’s Hims & Hers Health HIMS Stock Holding History

William Blair & Company’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$702K Sell
20,247
-1,292
-6% -$34.7K ﹤0.01% 1104
2026
Q1 		$447K Buy
21,539
+32
+0.1% +$756 ﹤0.01% 1188
2025
Q4 		$698K Sell
21,507
-11
-0.1% -$471 ﹤0.01% 1034
2025
Q3 		$1.22M Sell
21,518
-245
-1% -$12.6K ﹤0.01% 863
2025
Q2 		$1.08M Sell
21,763
-997
-4% -$45.1K ﹤0.01% 876
2025
Q1 		$673K Buy
22,760
+789
+4% +$29.3K ﹤0.01% 998
2024
Q4 		$531K Sell
21,971
-529
-2% -$13.1K ﹤0.01% 1082
2024
Q3 		$414K Hold
22,500
– – ﹤0.01% 1175
2024
Q2 		$454K Buy
22,500
+452
+2% +$7.52K ﹤0.01% 1123
2024
Q1 		$341K Sell
22,048
-80,333
-78% -$906K ﹤0.01% 1209
2023
Q4 		$911K Sell
102,381
-39,000
-28% -$288K ﹤0.01% 884
2023
Q3 		$889K Sell
141,381
-1,000
-0.7% -$7.44K ﹤0.01% 878
2023
Q2 		$1.34M Sell
142,381
-6,667
-4% -$66.1K ﹤0.01% 760
2023
Q1 		$1.48M Sell
149,048
-9,400
-6% -$82.4K 0.01% 728
2022
Q4 		$1.02M Sell
158,448
-5,075
-3% -$28.9K ﹤0.01% 819
2022
Q3 		$912K Sell
163,523
-2
-0% -$12 ﹤0.01% 845
2022
Q2 		$741K Sell
163,525
-4,950
-3% -$21.1K ﹤0.01% 947
2022
Q1 		$898K Sell
168,475
-1,250
-0.7% -$6.18K ﹤0.01% 959
2021
Q4 		$1.11M Sell
169,725
-29,669
-15% -$215K ﹤0.01% 914
2021
Q3 		$1.5M Buy
199,394
+75
+0% +$635 0.01% 776
2021
Q2 		$2.17M Buy
199,319
+70,621
+55% +$840K 0.01% 686
2021
Q1 		$1.7M Buy
+128,698
New +$2.16M 0.01% 732

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair & Company's HIMS Position: Q2 2026 in Review

William Blair & Company reduced its Hims & Hers Health (HIMS) stake by 6% in Q2 2026, selling an estimated $34.7K and leaving 20,247 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

William Blair & Company first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.17M in Q2 2021. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • William Blair & Company held 20,247 shares of Hims & Hers Health worth $702K as of Q2 2026.
  • William Blair & Company sold 1,292 Hims & Hers Health shares in Q2 2026, an estimated $34.7K.
  • Hims & Hers Health made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1104 holding.
  • William Blair & Company first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • William Blair & Company's Hims & Hers Health position peaked at $2.17M in Q2 2021.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.